Biomarin Pharmaceutical Inc - Net Worth and Insider Trading

Biomarin Pharmaceutical Inc Net Worth

The estimated net worth of Biomarin Pharmaceutical Inc is at least $107 Million dollars as of 2024-03-19. Biomarin Pharmaceutical Inc is the 10% Owner of Catalyst Pharmaceuticals Inc and owns about 6,666,667 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $107 Million. Details can be seen in Biomarin Pharmaceutical Inc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Biomarin Pharmaceutical Inc has not made any transactions after 2012-12-08 and currently still holds the listed stock(s).

Transaction Summary of Biomarin Pharmaceutical Inc

To

Biomarin Pharmaceutical Inc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Biomarin Pharmaceutical Inc owns 2 companies in total, including Catalyst Pharmaceuticals Inc () , and La Jolla Pharmaceutical Co () .

Click here to see the complete history of Biomarin Pharmaceutical Inc’s form 4 insider trades.

Insider Ownership Summary of Biomarin Pharmaceutical Inc

Ticker Comapny Transaction Date Type of Owner
Catalyst Pharmaceuticals Inc 2012-12-08 10 percent owner
La Jolla Pharmaceutical Co 2009-01-20 10 percent owner

Biomarin Pharmaceutical Inc Latest Holdings Summary

Biomarin Pharmaceutical Inc currently owns a total of 1 stock. Biomarin Pharmaceutical Inc owns 6,666,667 shares of Catalyst Pharmaceuticals Inc (CPRX) as of December 8, 2012, with a value of $107 Million.

Latest Holdings of Biomarin Pharmaceutical Inc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPRX Catalyst Pharmaceuticals Inc 2012-12-08 6,666,667 16.08 107,200,005

Holding Weightings of Biomarin Pharmaceutical Inc


Biomarin Pharmaceutical Inc Form 4 Trading Tracker

According to the SEC Form 4 filings, Biomarin Pharmaceutical Inc has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the acquisition of 5,000,000 shares on December 8, 2012, which cost Biomarin Pharmaceutical Inc around $4 Million.

Insider Trading History of Biomarin Pharmaceutical Inc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Biomarin Pharmaceutical Inc Trading Performance

GuruFocus tracks the stock performance after each of Biomarin Pharmaceutical Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Biomarin Pharmaceutical Inc is 14.29%. GuruFocus also compares Biomarin Pharmaceutical Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Biomarin Pharmaceutical Inc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Biomarin Pharmaceutical Inc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Biomarin Pharmaceutical Inc

Average Relative Return

359.52%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 40.48 14.29 104.76 359.52 156.02 80.65
Relative Return to S&P 500(%) 37.72 4.9 88.87 332.23 135.51 67.34

Biomarin Pharmaceutical Inc Ownership Network

Ownership Network List of Biomarin Pharmaceutical Inc

No Data

Ownership Network Relation of Biomarin Pharmaceutical Inc


Biomarin Pharmaceutical Inc Owned Company Details

What does Catalyst Pharmaceuticals Inc do?

Who are the key executives at Catalyst Pharmaceuticals Inc?

Biomarin Pharmaceutical Inc is the 10 percent owner of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Accounting Officer Alicia Grande , Chief Medical Officer Gary Ingenito , and VP Development & Management Steve Miller .

Catalyst Pharmaceuticals Inc () Insider Trades Summary

Over the past 18 months, Biomarin Pharmaceutical Inc made no insider transaction in Catalyst Pharmaceuticals Inc (). Other recent insider transactions involving Catalyst Pharmaceuticals Inc () include a net sale of 490,000 shares made by Alicia Grande , a net sale of 526,151 shares made by Patrick J Mcenany , and a net sale of 179,017 shares made by Carmen Jeffrey Del .

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,814,523 shares of Catalyst Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,814,523 shares.

Catalyst Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalyst Pharmaceuticals Inc Insider Transactions

No Available Data

Biomarin Pharmaceutical Inc Mailing Address

Above is the net worth, insider trading, and ownership report for Biomarin Pharmaceutical Inc. You might contact Biomarin Pharmaceutical Inc via mailing address: 105 Digital Drive, Novato Ca 94949.

Discussions on Biomarin Pharmaceutical Inc

No discussions yet.